Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Published:2022-03 Issue: Volume:128 Page:154962
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Bassatne Aya,Bou Khalil Abir,Chakhtoura Marlene,Arabi Asma,Van Poznak Catherine,El-Hajj Fuleihan Ghada

Funder

Fogarty International Center

National Institutes of Health

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference65 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG;Hadji;J Bone Oncol,2017

3. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Group EBCTC;Lancet,2015

4. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline;Shapiro;J Clin Oncol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors;Frontiers in Endocrinology;2023-11-21

2. Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer;Osteoporosis International;2023-01-30

3. Side effects of drugs for metabolic bone disease;Side Effects of Drugs Annual;2023

4. Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors;Calcified Tissue International;2022-07-28